Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

GMED
GLOBUS MEDICAL INC
stock NYSE

Market Open
Jul 14, 2025 2:44:56 PM EDT
57.40USD+0.499%(+0.28)750,058
55.00Bid   57.41Ask   2.41Spread
Pre-market
0.00USD-100.000%(-57.12)0
After-hours
Jul 11, 2025 4:00:30 PM EDT
57.12USD+0.061%(+0.04)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 7, 2022
01:04PM EST  Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $82   Benzinga
Jan 4, 2022
10:14AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022   Benzinga
05:24AM EST  Piper Sandler Upgrades Globus Medical to Overweight, Raises Price Target to $88   Benzinga
Dec 13, 2021
11:09AM EST  Why Did BofA Securities Give Globus Medical A Double Upgrade?   Benzinga
10:48AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2021   Benzinga
09:46AM EST  B of A Securities Upgrades Globus Medical to Buy, Raises Price Target to $80   Benzinga
Nov 15, 2021
12:57PM EST  BZ NOTE: Globus Medical Said To Make Early Takeover Approach For Nuvasive   Benzinga
Nov 5, 2021
09:32AM EDT  Globus Medical Reaffirms FY21 Guidance   Benzinga
09:32AM EDT  Globus Medical Q3 EPS $0.50 Beats $0.45 Estimate, Sales $229.72M Beat $228.35M Estimate   Benzinga
09:31AM EDT  Recap: Globus Medical Q3 Earnings   Benzinga
Nov 4, 2021
08:19AM EDT  The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO   Benzinga
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 19, 2021
04:31PM EDT  Globus Medical Outlines Features For Its New ANTHEM Mini Fragment Fracture System At Orthopaedic Trauma Association Meeting Oct. 20-23   Benzinga
04:30PM EDT  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will feature its new ANTHEM Mini Fragment Fracture System at the annual Orthopaedic Trauma Association (OTA) meeting in Fort Worth, Texas, Oct 20-23, 2021.   GlobeNewswire Inc
Oct 14, 2021
05:01PM EDT  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2021 after the market close on Thursday, November 4, 2021. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.   GlobeNewswire Inc
Oct 13, 2021
04:31PM EDT  Globus Medical Files Suit Against Life Spine For IP Infringement   Benzinga
Oct 4, 2021
01:25PM EDT  Globus Medical Option Alert: Dec 17 $75 Calls Sweep (18) near the Ask: 165 @ $5.199 vs 75 OI; Earnings 10/27 After Close [est] Ref=$76.61   Benzinga
Sep 28, 2021
10:11AM EDT  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate in the 36th Annual Meeting of the North American Spine Society (NASS) being held September 29 through October 2, 2021 at the Boston Convention and Exhibition Center.   GlobeNewswire Inc
Sep 27, 2021
04:31PM EDT  Globus Medical Announces First ExcelsiusGPS Cranial Surgery   Benzinga
04:30PM EDT  Globus Medical Announces First ExcelsiusGPS Cranial   GlobeNewswire Inc
Sep 3, 2021
07:31AM EDT  The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself   Benzinga
Aug 20, 2021
02:01PM EDT  Return on Capital Employed Insights for Globus Medical   Benzinga
Aug 17, 2021
06:15AM EDT  FDA Approves Globus Medical's Consolidated Imaging System   Benzinga
Aug 16, 2021
04:33PM EDT  Globus Medical Reports FDA 510(k) Clearance For Excelsius3D   Benzinga
04:30PM EDT  Globus Medical, Inc.(NYSE: GMED), a leading musculoskeletal solutions company, today announced that Excelsius3D, an intelligent intraoperative 3-in-1 imaging system, has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA).   GlobeNewswire Inc
Aug 5, 2021
10:16AM EDT  Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $90   Benzinga
09:07AM EDT  Citigroup Maintains Buy on Globus Medical, Raises Price Target to $93   Benzinga
09:03AM EDT  Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $80   Benzinga
08:38AM EDT  Credit Suisse Maintains Outperform on Globus Medical, Raises Price Target to $91   Benzinga
06:50AM EDT  SVB Leerink Maintains Outperform on Globus Medical, Raises Price Target to $96   Benzinga
05:45AM EDT  Needham Maintains Buy on Globus Medical, Raises Price Target to $92   Benzinga
Aug 4, 2021
05:34PM EDT  Globus Medical Sees FY21 Adj. EPS $1.89-$2.00 vs $1.89 Est., Sales $925M-$950M vs $926.78M Est.   Benzinga
05:33PM EDT  Globus Medical Q2 Adj. EPS $0.56 Beats $0.44 Estimate, Sales $251.02M Beat $224.64M Estimate   Benzinga
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Jul 30, 2021
07:54AM EDT  The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs   Benzinga
Jul 29, 2021
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 16, 2021
08:32AM EDT  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2021 after the market close on Wednesday, August 4, 2021. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.   GlobeNewswire Inc
Jul 15, 2021
04:33PM EDT  Globus Medical, Inc.(NYSE: GMED), a leading musculoskeletal solutions company,todayannouncedthat over 20,000 spine procedures have been performed utilizing theExcelsiusGPS Robotic Navigation system.   GlobeNewswire Inc
04:32PM EDT  Globus Medical Reports Completed 20K Procedures Using Its Excelsius GPS Robotic Navigation System   Benzinga
Jul 13, 2021
08:05AM EDT  The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data   Benzinga
Jul 12, 2021
10:14AM EDT  Stocks That Hit 52-Week Highs On Monday   Benzinga
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jul 2, 2021
07:38AM EDT  The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures   Benzinga
Jun 29, 2021
08:17AM EDT  The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 5, 2021
10:20AM EDT  Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $80   Benzinga
08:25AM EDT  Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $77   Benzinga
07:20AM EDT  Needham Maintains Buy on Globus Medical, Raises Price Target to $82   Benzinga
06:45AM EDT  SVB Leerink Maintains Outperform on Globus Medical, Raises Price Target to $81   Benzinga
May 4, 2021
05:22PM EDT  Recap: Globus Medical Q1 Earnings   Benzinga
05:07PM EDT  Globus Medical Sees FY21 EPS $1.83-$1.89 Vs. $1.84 Est., Sales $880M-$925M Vs. $881.64M Est.   Benzinga
05:06PM EDT  Globus Medical Q1 EPS $0.44 Beats $0.37 Estimate, Sales $227.34M Beat $198.39M Estimate   Benzinga
08:10AM EDT  The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data   Benzinga
Apr 23, 2021
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
Apr 22, 2021
08:09AM EDT  The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs   Benzinga
Apr 21, 2021
04:30PM EDT  Globus Medical, Inc.(NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2021 after the market close on Tuesday, May 4,2021. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.   GlobeNewswire Inc
Apr 16, 2021
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
Apr 15, 2021
04:30PM EDT  Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company,todayannouncedthe recent launchofCREO ONE, the marketsfirst robotic screwdesigned for spine surgery withExcelsiusGPS.   GlobeNewswire Inc
07:49AM EDT  The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split   Benzinga
Feb 22, 2021
09:13AM EST  Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $72   Benzinga
Feb 18, 2021
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
06:12AM EST  Needham Maintains Buy on Globus Medical, Raises Price Target to $75   Benzinga
Feb 17, 2021
04:47PM EST  Recap: Globus Medical Q4 Earnings   Benzinga
04:29PM EST  Globus Medical Sees FY21 Adj. EPS $1.83 vs $2.01 Estimate, Sales $880M vs $914M Est.   Benzinga
04:28PM EST  Globus Medical Q4 Adj. EPS $0.58 Beats $0.51 Estimate, Sales $233.40M Beat $231.22M Estimate   Benzinga
04:15PM EST  Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December31, 2020.   GlobeNewswire Inc
07:27AM EST  The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal   Benzinga
04:34AM EST  Earnings Scheduled For February 17, 2021   Benzinga
Jan 8, 2021
08:46AM EST  Credit Suisse Maintains Outperform on Globus Medical, Raises Price Target to $75   Benzinga
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Dec 17, 2020
08:10AM EST  The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut   Benzinga
Dec 16, 2020
07:15AM EST  The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal   Benzinga
Dec 15, 2020
12:08PM EST  Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $69   Benzinga
07:52AM EST  The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding   Benzinga
Dec 9, 2020
04:30PM EST  Globus Medical Reports Its Trauma Unit Wins Purchase Deal With Premier Inc., No Terms Disclosed   Benzinga
04:30PM EST  Globus Medical, Inc.(NYSE:GMED), a leading musculoskeletal solutions company, was recently awarded a group purchasing agreement with Premier, one of the largest group purchasing organizations in the United States. The agreement covers Globus Trauma Platform, which includes ANTHEM Plating, AUTOBAHN Nailing, ARBOR External Fixation, and CAPTIVATE Screw Platforms.   GlobeNewswire Inc
Dec 8, 2020
09:36AM EST  Benzinga's Top Upgrades, Downgrades For December 8, 2020   Benzinga
07:20AM EST  Citigroup Initiates Coverage On Globus Medical with Buy Rating, Announces Price Target of $72   Benzinga
Oct 28, 2020
04:57PM EDT  Globus Medical Q3 Adj. EPS $0.49 Beats $0.30 Estimate, Sales $216.10M Beat $195.87M Estimate   Benzinga
Oct 20, 2020
06:16AM EDT  Stifel Initiates Coverage On Globus Medical with Hold Rating, Announces Price Target of $56   Benzinga
Oct 16, 2020
04:30PM EDT  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2020 after the market close on Wednesday, October 28,2020. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.   GlobeNewswire Inc
Oct 5, 2020
04:30PM EDT  Globus Medical to Participate as Platinum Sponsor at North   GlobeNewswire Inc
Aug 6, 2020
02:22PM EDT  Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $56   Benzinga
01:36PM EDT  Piper Sandler Maintains Neutral on Globus Medical, Raises Price Target to $55   Benzinga
10:30AM EDT  Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $60   Benzinga
09:07AM EDT  Credit Suisse Maintains Outperform on Globus Medical, Raises Price Target to $58   Benzinga
08:45AM EDT  Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $58   Benzinga
05:36AM EDT  Needham Maintains Buy on Globus Medical, Raises Price Target to $65   Benzinga
05:09AM EDT  SVB Leerink Maintains Outperform on Globus Medical, Raises Price Target to $64   Benzinga
Aug 5, 2020
04:42PM EDT  Globus Medical Q2 EPS $0.70, May Not Compare To $(0.11) Estimate; Sales $148.92M Beat $99.73M Estimate   Benzinga
04:41PM EDT  Globus Medical Q2 Adj. EPS $0.70 Beats $(0.11) Estimate, Sales $148.92M Beat $99.73M Estimate   Benzinga
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 21, 2020
04:15PM EDT  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended June 30, 2020 after the market close on Wednesday, August 5,2020. A copy of the release will be available on the Globus Medical website atwww.globusmedical.com/investors.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC